ENTITY

Vigonvita Life Sciences (VVL HK)

11
Analysis
Health Care • China

•29 Nov 2025 11:05

Hong Kong: IPO SPOTLIGHT - OVERVIEW 2025

Hong Kong is the top global destination for IPOs in 2025, with over HK $280 billion raised so far.  Large scale A+H dual listings have surged this...

Logo
961 Views
Share
bullish•Alibaba
•11 Aug 2025 08:08

ECM Weekly (11 August 2025)-Bharti, Eternal, Paytm, LG CNS, Guming, JSW, Bluestone, SICC, Roborock

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
831 Views
Share
•05 Aug 2025 15:26

Vigonvita Life Sciences (旺山旺水) Pre-IPO: Structural Challenges for Commercialization

​Vigonvita seeks to raise $100 million in Hong Kong IPO with CITIC as book runner. We look at changes in the company's assets and progresses. We...

Logo
474 Views
Share
•29 May 2025 08:55

Pre-IPO Vigonvita Life Sciences - The Challenges Behind the Pipeline and the Outlook

Vigonvita's valuation hinges on innovative drug pipeline but excluding COVID-19 project. Series C financing boosts post-money valuation to RMB4.45...

Logo
589 Views
Share
bullish•Japan Post Bank
•03 Mar 2025 07:45

ECM Weekly (3rd Mar 2025) - Japan Post Bank, JX Advance, Mixue, Chifeng, JSW Cement, Premier, Guzman

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
748 Views
Share
x